The New Prostate Cancer Rules Format: Paperback

Steven Lamm, MD, Herbert Lepor, MD, Dan Sperling, MD

ISBN 10: 1938170318 / ISBN 13: 9781938170317

Editore: Spry Publishing LLC, 2013

Riguardo questo articolo

Brand New.

Codice articolo 9781938170317

Dati bibliografici

• Titolo: The New Prostate Cancer Rules Format: Paperback
• Editore: Spry Publishing LLC
• Data di pubblicazione: 2013
• Lingua: Inglese
• ISBN 10: 1938170318
• ISBN 13: 9781938170317
• Rilegatura: Brossura
• Condizione: New

Descrizione articolo

Riassunto

The most complete and accurate analysis of prostate cancer treatment, prevention, research, and technology available. Internationally renowned prostate cancer experts offer cutting-edge commentary on the questions that all modern men (and their loved ones and caretakers) need to have answered.

The past decade of breakthroughs in clinical research and unprecedented technological advancements has affected few medical conditions more than prostate cancer. Even the most up-to-date advice can vary significantly from one doctor to the next.

Enter Redefining Prostate Cancer: An Innovative Guide to Diagnosis and Treatment, the most complete and accurate analysis of prostate cancer treatment, prevention, research, and technology. Internationally renowned prostate cancer experts offer cutting-edge commentary on the questions that all modern men need to have answered. Arm yourself with Redefining Prostate Cancer and the confidence that your decisions are being made with the best possible information as your guide.

Recensione

Redefining Prostate Cancer is an outstanding resource for patients living with prostate cancer. The authors’ breadth of experience in prostate cancer diagnosis and treatment provides patients with the information they need to intelligently discuss their treatment options with their medical team. Informed patients are then able to find the treatment options that work best for them and their families. The information provided is up-to-date, practical, and accessible. This book should be provided to every patient diagnosed with prostate cancer.”
-Natan Bar-Chama, MD, Director of Male Reproductive Medicine and Surgery, Department of Urology, The Mount Sinai School of Medicine